Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients

被引：0
|
作者：
Duma, Narjust [1 ]
Azzouqa, Abdel-Ghani [1 ]
Yadav, Siddhartha [1 ]
Hoversten, Kahterine [1 ]
Reed, Clay [1 ]
Sitek, Andrea [1 ]
Enninga, Elizabeth [1 ]
Paludo, Jonas [1 ]
Kottschade, Lisa [1 ]
Mansfield, Aaron [1 ]
Manochakian, Rami [1 ]
Dronca, Roxana [1 ]
Adjei, Alex [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期
关键词：
D O I：
10.1158/1538-7755.DISP18-A120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A120
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer
    Osataphan, Soravis Alm
    Awidi, Muhammad
    Jan, Yu Jen
    Sundararaman, Shriram
    Viray, Hollis
    Frankenberger, Edward
    Mariano, Melissa
    Stafford, Katherine Ann
    Kolnick, Aleksandra
    Ghazalah, Hind
    Patti, Mary-Elizabeth
    Gunturu, Krishna Soujanya
    Rangachari, Deepa
    Costa, Daniel Botelho
    Lam, Prudence B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Somatic Gene Changes Associated with Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Pachimatla, A. G.
    Kalvapudi, S.
    Bawek, S.
    Vedire, Y.
    Jain, P.
    Yendamuri, S.
    Patnaik, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S597 - S598
  • [43] The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
    Nicos, Marcin
    Krawczyk, Pawel
    Crosetto, Nicola
    Milanowski, Janusz
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
    Vansteenkiste, Johan F.
    ESMO OPEN, 2018, 3 (06)
  • [45] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Kobayashi, Haruki
    RESPIROLOGY, 2020, 25 (08) : 892 - 893
  • [46] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Matsumoto, Kinnosuke
    Adachi, Yuichi
    Enomoto, Takatoshi
    RESPIROLOGY, 2020,
  • [47] The progresses of relevant factors on the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patients
    Yu, Zhaoqing
    Qin, Li
    Yu, Guifang
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 37
  • [48] Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection
    Banna, Giuseppe Luigi
    Passiglia, Francesco
    Colonese, Francesca
    Canova, Stefania
    Menis, Jessica
    Addeo, Alfredo
    Russo, Antonio
    Cortinovis, Diego Luigi
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 27 - 39
  • [49] Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender
    Zheng, S-Y.
    Cui, H-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S715 - S715
  • [50] Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
    Isono, Taisuke
    Furuno, Hajime
    Onodera, Yoko
    Maruyama, Tomoya
    Takeuchi, Yuki
    Kojima, Ayaka
    Nishida, Takashi
    Kobayashi, Yoichi
    Ishiguro, Takashi
    Takaku, Yotaro
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 951 - 959
12345